STOCK TITAN

Core Scientific director exercises 30,000 warrants

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Core Scientific, Inc. (CORZ) director Yadin Rozov exercised 30,000 Tranche 1 Warrants on November 11, 2026, at an exercise price of $6.81 per share, acquiring 30,000 shares of common stock. His direct common-stock holdings after the transaction were 484,162 shares. Each whole warrant entitled its registered holder to purchase one common share, subject to certain adjustments.

Insider Rozov Yadin
Role Director
Type Security Shares Price Value
In-the-Money Exercise Tranche 1 Warrants F1 30,000 $0.00 $0.00
In-the-Money Exercise Common Stock 30,000 $6.81 $204K
Holdings After Transaction: Tranche 1 Warrants — 0 warrants (Direct); Common Stock — 484,162 shares (Direct)
Footnotes (1)
  1. F1. Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $6.81 per share, subject to certain adjustments.
Tranche 1 Warrants exercised 30,000 warrants November 11, 2026
Common shares acquired 30,000 shares Through warrant exercise on November 11, 2026
Exercise price $6.81 per share Tranche 1 Warrants
Direct common shares held after transaction 484,162 shares Yadin Rozov's reported position following the transaction
Tranche 1 Warrants technical
"exercised 30,000 Tranche 1 Warrants"
exercise price financial
"at an exercise price of $6.81 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
subject to certain adjustments technical
"at an exercise price of $6.81 per share, subject to certain adjustments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CORZ shares did Yadin Rozov receive from warrant exercise?

Yadin Rozov exercised 30,000 Tranche 1 Warrants on November 11, 2026, and acquired 30,000 common shares at $6.81 per share; his direct common-stock holdings afterward were 484,162 shares.

What did each CORZ Tranche 1 Warrant entitle its holder to purchase?

Each whole Tranche 1 Warrant entitled its registered holder to purchase one share of Core Scientific common stock at an exercise price of $6.81 per share, subject to certain adjustments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rozov Yadin

(Last)(First)(Middle)
C/O CORE SCIENTIFIC, INC.
838 WALKER ROAD, SUITE 21-2105

(Street)
DOVER DELAWARE 19904

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Core Scientific, Inc./tx [ CORZ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/11/2026X30,000A$6.81484,162D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Tranche 1 Warrants$6.8111/11/2026X30,00001/23/2024(1)01/23/2027Common Stock30,000$00D
Explanation of Responses:
1. Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $6.81 per share, subject to certain adjustments.
/s/ Todd DuChene, as Attorney-in-Fact11/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading